Okay, let's tackle this question about drugs used in leprosy. The user wants a detailed explanation for an MCQ where the correct answer is the false statement. First, I need to recall the standard treatment regimens for leprosy. Leprosy, also known as Hansen's disease, is treated with multidrug therapy (MDT) to prevent resistance. The WHO-recommended regimen includes rifampicin, dapsone, and clofazimine.

The question is asking which statement is false. The correct answer is probably a statement that contradicts the standard MDT guidelines. Common false statements might include incorrect dosages, duration of treatment, or drug interactions. For example, if an option says dapsone is used alone, that's false because monotherapy leads to resistance. Another might claim that rifampicin is given daily, but actually, it's given once a month under supervision. Also, clofazimine's role in both paucibacillary and multibacillary forms is important.

I need to structure the explanation with the core concept first. The core is about MDT for leprosy and the drugs involved. Then, the correct answer explanation should detail why the false statement is incorrect, maybe about dosage or regimen. For each wrong option, explain why they are true. The clinical pearl would be the MDT components and their administration. Finally, confirm the correct answer as the false one.

**Core Concept**
Leprosy (Hansen’s disease) is managed with multidrug therapy (MDT) to prevent drug resistance. The World Health Organization (WHO) recommends **rifampicin**, **dapsone**, and **clofazimine** as first-line agents. Regimens differ for paucibacillary (PB) and multibacillary (MB) leprosy, with rifampicin administered monthly under direct observation.

**Why the Correct Answer is Right**
The false statement likely claims **dapsone monotherapy is effective**, which is incorrect. Dapsone alone promotes rapid resistance due to *Mycobacterium leprae*’s slow replication and low drug pressure. MDT is mandatory; rifampicin (bactericidal) and clofazimine (bacteriostatic) are added to dapsone to prevent resistance.

**Why Each Wrong Option is Incorrect**
**Option A:** "Rifampicin is bactericidal" – Correct. Rifampicin inhibits RNA synthesis and is highly bactericidal.
**Option B:** "Clofazimine has anti-inflammatory properties" – Correct. It modulates macrophage function and reduces granulomatous inflammation.
**Option C:** "Dapsone is a synthetic antimicrobial agent" – Correct. It inhibits dihydropteroate synthase in *M. leprae*.

**Clinical Pearl / High-Yield Fact**
Never prescribe **monotherapy** for leprosy. Resistance is inevitable without MDT. Remember the **WHO MDT regimen**:
- **PB leprosy**: Rifampicin (600 mg monthly) + dapsone (100 mg daily) × 6 months.
- **MB leprosy**: Rifampicin + dapsone + clofazim

✓ Correct Answer: C. Clofazimine should not be given to patients who are intolerant to dapsone or who fail to improve during treatment with dapsone